Highlights from the 2023 Psych Congress
Diagnosing Suspected MS: A Review of the Updated Guidelines
Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea
The Epidemiology of Sleepiness in Obstructive Sleep Apnea
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Negative Impacts of Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Studying the Safety of Discontinuing DMTs in MS Older Adults
Uncovering Disease Progression in Multiple Sclerosis
Clinical and Practical Viability of RWE – What Now?
What Future Studies Are Out There on the Meaningfulness of Reversal in ICH?
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for ICH?
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for GI Bleeds?
Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?
What’s the Best Available Evidence for Reversal of Life-Threatening Bleeds?
Anticoagulant-Associated Major Bleeding Is a Significant Problem: How Do I Address?